IL149593A0 - Solid state forms of 5-[[6-[(2-fluorophenyl)methoxy]-2-naphthalenyl] methyl]-2,4-thiazolidinedione - Google Patents

Solid state forms of 5-[[6-[(2-fluorophenyl)methoxy]-2-naphthalenyl] methyl]-2,4-thiazolidinedione

Info

Publication number
IL149593A0
IL149593A0 IL14959300A IL14959300A IL149593A0 IL 149593 A0 IL149593 A0 IL 149593A0 IL 14959300 A IL14959300 A IL 14959300A IL 14959300 A IL14959300 A IL 14959300A IL 149593 A0 IL149593 A0 IL 149593A0
Authority
IL
Israel
Prior art keywords
thiazolidinedione
naphthalenyl
fluorophenyl
methoxy
methyl
Prior art date
Application number
IL14959300A
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of IL149593A0 publication Critical patent/IL149593A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
IL14959300A 1999-11-19 2000-11-17 Solid state forms of 5-[[6-[(2-fluorophenyl)methoxy]-2-naphthalenyl] methyl]-2,4-thiazolidinedione IL149593A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16651599P 1999-11-19 1999-11-19
PCT/US2000/031705 WO2001036401A1 (en) 1999-11-19 2000-11-17 Solid state forms of 5-[[6-[(2-fluorophenyl)methoxy]-2-naphthalenyl]methyl]-2,4-thiazolidinedione

Publications (1)

Publication Number Publication Date
IL149593A0 true IL149593A0 (en) 2002-11-10

Family

ID=22603643

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14959300A IL149593A0 (en) 1999-11-19 2000-11-17 Solid state forms of 5-[[6-[(2-fluorophenyl)methoxy]-2-naphthalenyl] methyl]-2,4-thiazolidinedione

Country Status (16)

Country Link
EP (1) EP1235817A1 (en)
JP (1) JP2003514807A (en)
CN (1) CN1423639A (en)
AR (1) AR029409A1 (en)
AU (1) AU1776701A (en)
BG (1) BG106692A (en)
BR (1) BR0015702A (en)
CA (1) CA2391429A1 (en)
HU (1) HUP0203280A3 (en)
IL (1) IL149593A0 (en)
MX (1) MXPA02005008A (en)
NO (1) NO20022329L (en)
RU (1) RU2002113123A (en)
WO (1) WO2001036401A1 (en)
YU (1) YU35602A (en)
ZA (1) ZA200204873B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104055774A (en) * 2013-03-22 2014-09-24 天津药物研究院 Stable amorphous pioglitazone hydrochloride compound

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2845743B2 (en) * 1992-12-28 1999-01-13 三菱化学株式会社 New naphthalene derivatives
US5594016A (en) * 1992-12-28 1997-01-14 Mitsubishi Chemical Corporation Naphthalene derivatives
JP4023697B2 (en) * 1996-11-14 2007-12-19 三菱化学株式会社 Method for producing naphthalene derivative
TR200202110T2 (en) * 1998-11-20 2002-10-21 Mitsubishi Chemical Corporation "5 - [{6- (2-Fluorine benzyl) oxy-2-naphthyl} methyl] -2,4-thiazolidine dion crystals"

Also Published As

Publication number Publication date
AU1776701A (en) 2001-05-30
RU2002113123A (en) 2004-01-20
NO20022329D0 (en) 2002-05-15
HUP0203280A2 (en) 2003-01-28
MXPA02005008A (en) 2003-10-14
NO20022329L (en) 2002-07-09
CN1423639A (en) 2003-06-11
WO2001036401A1 (en) 2001-05-25
BG106692A (en) 2003-03-31
BR0015702A (en) 2002-07-16
HUP0203280A3 (en) 2003-07-28
YU35602A (en) 2006-05-25
ZA200204873B (en) 2003-11-26
AR029409A1 (en) 2003-06-25
CA2391429A1 (en) 2001-05-25
EP1235817A1 (en) 2002-09-04
JP2003514807A (en) 2003-04-22

Similar Documents

Publication Publication Date Title
IL147108A0 (en) Substituted heterocycle fused gamma-carbolines
AU2001262150A1 (en) 2-(nitrogen-heterocyclic)pyrimidone derivatives
HK1036521A1 (en) Laminative ceramic condenser
AU4556700A (en) Pyrimidine compounds
AU2002216314A1 (en) Heterocyclic angiogenesis inhibitors
ZA972973B (en) Substituted [2-(1-piperazinyl)ethoxy]methyl compounds.
DE50105770D1 (en) Di(het)arylaminothiophen-derivate
ZA9810033B (en) Process for the preparation of Thiazolidinedione Derivatives.
AP2002002512A0 (en) Novel thiazolidinedione
SG88768A1 (en) Delay circuit for ring oscillator
AU2001258841A1 (en) Heterocyclic compounds
AU5884101A (en) Heterocyclic compounds
MXPA02001117A (en) Heterocyclic compounds inhibiting angiogenesis.
IL149593A0 (en) Solid state forms of 5-[[6-[(2-fluorophenyl)methoxy]-2-naphthalenyl] methyl]-2,4-thiazolidinedione
HUP0104139A3 (en) Chrystals of 5-[{6-(2-fluorobenzyl)oxy-2-naphthyl}methyl]-2,4-thiazolidinedione
AU1882900A (en) Assay for homocysteine
AUPP921299A0 (en) New heterocyclic compounds
AU2001262729A1 (en) 4-oxoimidazolidine-2-spiro-nitrogenous heterocycle compounds
MXPA03001550A (en) Catalytic process for the preparation of thiazole derivatives.
HUP0103517A3 (en) Improved process for the preparation of thiazolidine-2,4-dione derivatives
HUP0400485A3 (en) Process for the preparation of 5-phenylpentanoyl-ala-arginyl-{2-[3-amino-2-oxopyrrolidin-1-yl]propionyl}-alanyl-arginyl-alanyl-4-aminophenylacetamide
AU2001236048A1 (en) Oxygen-containing heterocyclic compounds
HUP0300723A3 (en) Process for the preparation of 5-[(4-chlorophenyl)-methyl]-2,2-dimethylcylopentanone
AU2000229051A1 (en) Scraper for centrifuges
MXPA02003554A (en) Separation of halogenated compounds.